Zimmer Biomet Holdings Interest Income (Expense), Operating increased by 4.3% to -$68.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.9%, from -$66.20M to -$68.80M. Over 4 years (FY 2021 to FY 2025), Interest Income (Expense), Operating shows a downward trend with a 8.9% CAGR.
A net expense indicates debt-heavy financing, while net income suggests a strong cash position or high-yield investments.
Net interest income or expense represents the difference between interest earned on cash and investments and interest pa...
Depends on the capital structure; defense companies typically maintain moderate leverage to fund long-term projects.
other_interest_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$54.70M | -$52.60M | -$48.80M | -$41.10M | -$38.80M | -$42.30M | -$42.60M | -$48.20M | -$51.60M | -$51.10M | -$50.30M | -$50.70M | -$51.10M | -$54.30M | -$61.90M | -$66.20M | -$79.30M | -$75.40M | -$71.90M | -$68.80M |
| QoQ Change | — | +3.8% | +7.2% | +15.8% | +5.6% | -9.0% | -0.7% | -13.1% | -7.1% | +1.0% | +1.6% | -0.8% | -0.8% | -6.3% | -14.0% | -6.9% | -19.8% | +4.9% | +4.6% | +4.3% |
| YoY Change | — | — | — | — | +29.1% | +19.6% | +12.7% | -17.3% | -33.0% | -20.8% | -18.1% | -5.2% | +1.0% | -6.3% | -23.1% | -30.6% | -55.2% | -38.9% | -16.2% | -3.9% |